Karen E. Connor

2.5k total citations · 1 hit paper
6 papers, 2.1k citations indexed

About

Karen E. Connor is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karen E. Connor has authored 6 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Neurology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karen E. Connor's work include Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Nuclear Receptors and Signaling (2 papers). Karen E. Connor is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Nuclear Receptors and Signaling (2 papers). Karen E. Connor collaborates with scholars based in United States, Italy and Canada. Karen E. Connor's co-authors include Marcia N. Gordon, Paul Jantzen, Giovanni DiCarlo, Dave Morgan, Donna M. Wilcock, Chad A. Dickey, Paul E. Gottschall, Kenneth E. Ugen, John Hardy and David M. Diamond and has published in prestigious journals such as Nature, Journal of Neuroscience and The Journal of Physiology.

In The Last Decade

Karen E. Connor

5 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

2000 1.2k citations Dave Morgan, David M. Diamond et al. Nature profile →

Peers

Countries citing papers authored by Karen E. Connor

Since Specialization

Citations

This map shows the geographic impact of Karen E. Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Connor more than expected).

Fields of papers citing papers by Karen E. Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Connor. The network helps show where Karen E. Connor may publish in the future.

Co-authorship network of co-authors of Karen E. Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Connor. A scholar is included among the top collaborators of Karen E. Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Connor. Karen E. Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Can heat stress augment the cerebrovascular and neurotrophic benefits of exercise? 2025 ·The Journal of Physiology ·(unknown), (unknown), Karen E. Connor, (unknown)	0
2	Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models 2004 ·Neurobiology of Aging ·Nilay Patel, Marcia N. Gordon, Karen E. Connor, Robert A. Good, Robert W. Engelman, (unknown), David Morgan, Todd E. Morgan, Caleb E. Finch	259
3	Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse 2002 ·Experimental Neurology ·Marcia N. Gordon, Leigh A. Holcomb, Paul Jantzen, Giovanni DiCarlo, Donna M. Wilcock, (unknown), Karen E. Connor, (unknown), James P. O’Callaghan, Dave Morgan	206
4	Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice 2002 ·Journal of Neuroscience ·Paul Jantzen, Karen E. Connor, Giovanni DiCarlo, Gary L. Wenk, John L. Wallace, Amyn M. Rojiani, Domenico Coppola, Dave Morgan, Marcia N. Gordon	289
5	Number of A β Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque Levels 2001 ·DNA and Cell Biology ·Donna M. Wilcock, Marcia N. Gordon, Kenneth E. Ugen, Paul E. Gottschall, Giovanni DiCarlo, Chad A. Dickey, (unknown), Paul Jantzen, Karen E. Connor, (unknown), John Hardy, David Morgan	77
6	Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease breakdown → 2000 ·Nature ·Dave Morgan, David M. Diamond, Paul E. Gottschall, Kenneth E. Ugen, Chad A. Dickey, John Hardy, Karen Duff, Paul Jantzen, Giovanni DiCarlo, Donna M. Wilcock, Karen E. Connor, Jaime M. Hatcher, Caroline E. Hope, Marcia N. Gordon, Gary W. Arendash	1237

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact